WaveSense Receives CE-IVD Mark for Cell Enrichment Platform | GenomeWeb

NEW YORK (GenomeWeb) – WaveSense, a company developing a platform for rare cell isolation and enrichment, said today that it has received CE-IVD marking for its technologies.

The approval includes the company's EpiSep direct-to-slide cell enrichment technology, as well as its proprietary paramagnetic bead technology, which allows for selective isolation of cells that express CD138.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.